CJ cheiljedang's incrementally modified drug for diabetes treatment 'Vogmet' recently acquired a patent

CJ cheiljedang's incrementally modified drug for diabetes treatment 'Vogmet (Voglibose + Metformin)' recently acquired a patent from the Korean Intellectual Property Office, getting the recognition of improving hypoglycemia and gastrointestinal side effects.

In this patent, Vogmet received recognition for reducing gastrointestinal side effects such as abdominal distension and diarrhea which ...